Ge healthcare launches ai-driven, patient-friendly invenia abus premium to accelerate scanning and drive early cancer detection in dense breasts

Chicago--(business wire)--ge healthcare (nasdaq: gehc) announced the launch of invenia™ automated breast ultrasound (abus) premium, the latest 3d ultrasound offering advanced artificial intelligence (ai) and innovative features to drive faster*, reproducible supplemental screening and streamline exam readings on patients with dense breasts. approximately 71% of cancers occur in dense breasts.1 according to studies across the u.s. and europe, 40% of women2 and 70% of asian women3 have dense brea.
GEHC Ratings Summary
GEHC Quant Ranking